Cellulitis Diagnostic Needs Briefing

> Research explainer: This briefing examines verified primary research published 57 days before the briefing date. It is not a same-day research update and does not provide medical advice.

This DiseaseSignal Skin & Dermatology briefing examines a qualitative study of healthcare professionals’ experiences of diagnosing cellulitis in UK community and secondary-care settings. The source is suited to describing reported diagnostic challenges, perceived unmet needs, and preferences for possible diagnostic aids. It does not evaluate a diagnostic test, estimate disease frequency, or establish whether any proposed approach improves outcomes.

Evidence

The study used semistructured interviews with 25 UK healthcare professionals who had recent experience managing cellulitis. Participants included nurses, paramedics, pharmacists, general practitioners, and hospital physicians; interviews were conducted across community and hospital-based care. The researchers identified four major themes concerning diagnostic challenges and unmet needs in cellulitis diagnosis.

Participants described several circumstances they believed could make diagnosis difficult: atypical or recurrent presentations, high-risk patients, pre-existing wounds or ulcers, darker skin tones, and prior antibiotic use. These were presented as potential use cases where a diagnostic aid might be deployed, rather than as validated criteria for any particular test.

Interviewees also described clinician and patient behaviours they viewed as contributing to misdiagnosis. Reported factors included treating cellulitis as a default diagnosis, limited dermatology or tissue-viability knowledge and access, concern about the consequences of not treating, and patient expectations. The source frames these as participant perspectives from qualitative interviews.

Participants regarded existing candidate diagnostic aids as insufficiently specific. While they expressed interest in possible new technologies, they also raised concerns about usability, patient comfort, infection control, and training. Their preferred characteristics for an ideal test were portability, rapid results, equity, usability in both community and hospital settings, and a probabilistic result rather than a binary output.

The authors concluded that cellulitis remains diagnostically challenging across multiple care settings and that greater diagnostic specificity could help distinguish patients requiring antibiotics from those with non-infective inflammation. That conclusion identifies a development need; it is not evidence that a particular tool has achieved this distinction.

Analysis — Interview-defined diagnostic needs

The study’s principal contribution is a structured description of where participating professionals perceive uncertainty in cellulitis diagnosis and what constraints a future aid would need to address. The reported challenges span patient presentation, access to relevant expertise, and the practical realities of care delivery. This makes the findings useful for framing research questions and product requirements, especially where an aid would have to function across community and hospital settings.

The preference for a probabilistic result is notable because it reflects participant interest in support for clinical uncertainty rather than a simple yes-or-no classification. However, this is a stated design preference, not a validated performance standard. Similarly, concerns about comfort, infection control, training, and usability indicate that participants evaluated potential tools through implementation considerations as well as diagnostic specificity.

The findings should therefore be interpreted as evidence about professional experience and perceived unmet need. They support further stakeholder-informed development and evaluation of diagnostic approaches, but do not show that any candidate technology is accurate, clinically effective, equitable in use, or capable of reducing antibiotic use, healthcare attendance, or admission. The study also does not establish which reported barriers are most important, how often they occur, or whether they differ across healthcare systems.

Limitations

This was a qualitative study of reported experiences rather than a diagnostic-accuracy, clinical-effectiveness, or implementation trial. It did not test existing or proposed diagnostic technologies. Some discussion of potential tools was hypothetical, which limits how directly those responses can be applied to actual products or workflows.

The sample comprised 25 UK-based healthcare professionals, and the source states that findings may not fully reflect diagnostic pathways or specialist access in other healthcare systems. Qualitative themes also should not be treated as prevalence estimates or causal proof. In particular, the evidence does not establish the frequency of diagnostic difficulty, the effectiveness of any diagnostic aid, or patient-level implications. The briefing accordingly confines its conclusions to participant-reported experiences and stated preferences.